Click for best price
Transmucosal Drug Delivery Systems Market Size, Share 2022
The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first pass metabolism.
This report contains market size and forecasts of Transmucosal Drug Delivery Systems in Global, including the following market information:
The global Transmucosal Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drug Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transmucosal Drug Delivery Systems include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, Acrux Limited, ALZA Corporation, DURECT Corporation and Generex Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transmucosal Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transmucosal Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Transmucosal Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
- Oral Drug Delivery
- Nasal Drug Delivery
- Rectal Drug Delivery
- Other
Global Transmucosal Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Transmucosal Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Global Transmucosal Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Transmucosal Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Transmucosal Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Transmucosal Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- 3M
- Antares Pharma
- Aveva Drug Delivery Systems
- Corium International
- Acrux Limited
- ALZA Corporation
- DURECT Corporation
- Generex Biotechnology
| Report Attributes |
Report Details |
| Report Title |
Transmucosal Drug Delivery Systems Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Transmucosal Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transmucosal Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transmucosal Drug Delivery Systems Overall Market Size
2.1 Global Transmucosal Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Transmucosal Drug Delivery Systems Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transmucosal Drug Delivery Systems Players in Global Market
3.2 Top Global Transmucosal Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Transmucosal Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Transmucosal Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.5 Global Companies Transmucosal Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transmucosal Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Transmucosal Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Transmucosal Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Oral Drug Delivery
4.1.3 Nasal Drug Delivery
4.1.4 Rectal Drug Delivery
4.1.5 Other
4.2 By Type - Global Transmucosal Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Transmucosal Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type - Global Transmucosal Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type - Global Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transmucosal Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Transmucosal Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Transmucosal Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application - Global Transmucosal Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application - Global Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Transmucosal Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Transmucosal Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Transmucosal Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region - Global Transmucosal Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region - Global Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Transmucosal Drug Delivery Systems Revenue, 2017-2028
6.3.2 US Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.3.3 Canada Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.3.4 Mexico Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Transmucosal Drug Delivery Systems Revenue, 2017-2028
6.4.2 Germany Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.4.3 France Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.4.4 U.K. Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.4.5 Italy Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.4.6 Russia Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.4.7 Nordic Countries Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.4.8 Benelux Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Transmucosal Drug Delivery Systems Revenue, 2017-2028
6.5.2 China Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.5.3 Japan Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.5.4 South Korea Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.5.5 Southeast Asia Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.5.6 India Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Transmucosal Drug Delivery Systems Revenue, 2017-2028
6.6.2 Brazil Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.6.3 Argentina Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transmucosal Drug Delivery Systems Revenue, 2017-2028
6.7.2 Turkey Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.7.3 Israel Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.7.4 Saudi Arabia Transmucosal Drug Delivery Systems Market Size, 2017-2028
6.7.5 UAE Transmucosal Drug Delivery Systems Market Size, 2017-2028
7 Players Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Transmucosal Drug Delivery Systems Major Product Offerings
7.1.4 3M Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.1.5 3M Key News
7.2 Antares Pharma
7.2.1 Antares Pharma Corporate Summary
7.2.2 Antares Pharma Business Overview
7.2.3 Antares Pharma Transmucosal Drug Delivery Systems Major Product Offerings
7.2.4 Antares Pharma Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.2.5 Antares Pharma Key News
7.3 Aveva Drug Delivery Systems
7.3.1 Aveva Drug Delivery Systems Corporate Summary
7.3.2 Aveva Drug Delivery Systems Business Overview
7.3.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Major Product Offerings
7.3.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.3.5 Aveva Drug Delivery Systems Key News
7.4 Corium International
7.4.1 Corium International Corporate Summary
7.4.2 Corium International Business Overview
7.4.3 Corium International Transmucosal Drug Delivery Systems Major Product Offerings
7.4.4 Corium International Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.4.5 Corium International Key News
7.5 Acrux Limited
7.5.1 Acrux Limited Corporate Summary
7.5.2 Acrux Limited Business Overview
7.5.3 Acrux Limited Transmucosal Drug Delivery Systems Major Product Offerings
7.5.4 Acrux Limited Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.5.5 Acrux Limited Key News
7.6 ALZA Corporation
7.6.1 ALZA Corporation Corporate Summary
7.6.2 ALZA Corporation Business Overview
7.6.3 ALZA Corporation Transmucosal Drug Delivery Systems Major Product Offerings
7.6.4 ALZA Corporation Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.6.5 ALZA Corporation Key News
7.7 DURECT Corporation
7.7.1 DURECT Corporation Corporate Summary
7.7.2 DURECT Corporation Business Overview
7.7.3 DURECT Corporation Transmucosal Drug Delivery Systems Major Product Offerings
7.7.4 DURECT Corporation Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.7.5 DURECT Corporation Key News
7.8 Generex Biotechnology
7.8.1 Generex Biotechnology Corporate Summary
7.8.2 Generex Biotechnology Business Overview
7.8.3 Generex Biotechnology Transmucosal Drug Delivery Systems Major Product Offerings
7.8.4 Generex Biotechnology Transmucosal Drug Delivery Systems Revenue in Global Market (2017-2022)
7.8.5 Generex Biotechnology Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Transmucosal Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Transmucosal Drug Delivery Systems Market Drivers in Global Market
Table 3. Transmucosal Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Transmucosal Drug Delivery Systems in Global Market
Table 5. Top Transmucosal Drug Delivery Systems Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Transmucosal Drug Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Transmucosal Drug Delivery Systems Revenue Share by Companies, 2017-2022
Table 8. Global Companies Transmucosal Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Transmucosal Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Transmucosal Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Transmucosal Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Transmucosal Drug Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Transmucosal Drug Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Transmucosal Drug Delivery Systems Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Transmucosal Drug Delivery Systems Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 30. 3M Corporate Summary
Table 31. 3M Transmucosal Drug Delivery Systems Product Offerings
Table 32. 3M Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 33. Antares Pharma Corporate Summary
Table 34. Antares Pharma Transmucosal Drug Delivery Systems Product Offerings
Table 35. Antares Pharma Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 36. Aveva Drug Delivery Systems Corporate Summary
Table 37. Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Product Offerings
Table 38. Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 39. Corium International Corporate Summary
Table 40. Corium International Transmucosal Drug Delivery Systems Product Offerings
Table 41. Corium International Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 42. Acrux Limited Corporate Summary
Table 43. Acrux Limited Transmucosal Drug Delivery Systems Product Offerings
Table 44. Acrux Limited Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 45. ALZA Corporation Corporate Summary
Table 46. ALZA Corporation Transmucosal Drug Delivery Systems Product Offerings
Table 47. ALZA Corporation Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 48. DURECT Corporation Corporate Summary
Table 49. DURECT Corporation Transmucosal Drug Delivery Systems Product Offerings
Table 50. DURECT Corporation Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 51. Generex Biotechnology Corporate Summary
Table 52. Generex Biotechnology Transmucosal Drug Delivery Systems Product Offerings
Table 53. Generex Biotechnology Transmucosal Drug Delivery Systems Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Transmucosal Drug Delivery Systems Segment by Type in 2021
Figure 2. Transmucosal Drug Delivery Systems Segment by Application in 2021
Figure 3. Global Transmucosal Drug Delivery Systems Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Transmucosal Drug Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Transmucosal Drug Delivery Systems Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transmucosal Drug Delivery Systems Revenue in 2021
Figure 8. By Type - Global Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 9. By Application - Global Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 10. By Region - Global Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 11. By Country - North America Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 12. US Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 16. Germany Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 17. France Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 24. China Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 28. India Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 30. Brazil Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Transmucosal Drug Delivery Systems Revenue Market Share, 2017-2028
Figure 33. Turkey Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Transmucosal Drug Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 37. 3M Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Antares Pharma Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Corium International Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Acrux Limited Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ALZA Corporation Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. DURECT Corporation Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Generex Biotechnology Transmucosal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
